Intra-Cellular Stock Story

ITCI
 Stock
  

USD 55.17  1.91  3.35%   

Intra-Cellular investor sentiment overview provides quick insight into current market opportunities from investing in Intra-Cellular Ther. The current market sentiment together Intra-Cellular Ther's historical and current headlines can help investors to time the market. Many technical investors use Intra-Cellular Ther stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please see Intra-Cellular Ther Hype Analysis, Intra-Cellular Ther Correlation and Intra-Cellular Ther Performance.
  
Refresh
Intra-Cellular Ther stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Intra-Cellular daily returns and investor perception about the current pice of Intra-Cellular Ther as well as its diversification or hedging effects on your existing portfolios.

Intra-Cellular Latest Sentiment Indicators

200 Day MA
49.4
Short Percent
0.0438
Short Ratio
5.22
Shares Short Prior Month
3.1 M
50 Day MA
55.0
52 Week Low
28.4
Shares Short
3.6 M

Intra-Cellular Ther Current Investor Sentiment

Investor biases related to Intra-Cellular Ther's public news can be used to forecast risks associated with investment in Intra-Cellular. The trend in average sentiment can be used to explain how an investor holding Intra-Cellular can time the market purely based on public headlines and social activities around Intra-Cellular Ther. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Intra-Cellular Ther's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Intra-Cellular Ther's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Intra-Cellular Ther's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Intra-Cellular Ther.

Intra-Cellular Ther Maximum Pain Price across 2022-07-15 Option Contracts

Intra-Cellular Ther's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Intra-Cellular Ther close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Intra-Cellular Ther's options.
Exercise or conversion by Joel Marcus of 14189 shares of Intra-Cellular Ther subject to Rule 16b-3
Filed transaction by Intracellular Therapies I director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Intra-Cellular insider trading alert for exercise of restricted stock units by Joel Marcus, the corporate stakeholder, on 13th of May 2022. This event was filed by Intracellular Therapies I with SEC on 2022-05-13. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Intra-Cellular Ther's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Intra-Cellular Ther's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Intra-Cellular Ther Fundamental Analysis

We analyze Intra-Cellular Ther's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intra-Cellular Ther using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intra-Cellular Ther based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Intra-Cellular Ther is currently under evaluation in ebitda category among related companies. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Intra-Cellular Ther Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intra-Cellular Ther stock to make a market-neutral strategy. Peer analysis of Intra-Cellular Ther could also be used in its relative valuation, which is a method of valuing Intra-Cellular Ther by comparing valuation metrics with similar companies.

Peers

Intra-Cellular Ther Related Equities

KOCoca-Cola   2.34   
0%
81.0%
PGProcter Gamble   1.61   
0%
56.0%
JNJJohnson Johnson   1.13   
0%
39.0%
MSFTMicrosoft Corp   1.07   
0%
37.0%
BLUBellus Health   0.65   
0%
22.0%
IBMInternational Business Machines   0.05   
1.0%
0%
CSCOCisco Systems   0.09   
3.0%
0%
PFEPfizer Inc   0.23   
8.0%
0%
DDDupont Denemours   1.49   
52.0%
0%
INTCIntel Corp   2.86   
100.0%
0%
Please see Intra-Cellular Ther Hype Analysis, Intra-Cellular Ther Correlation and Intra-Cellular Ther Performance. Note that the Intra-Cellular Ther information on this page should be used as a complementary analysis to other Intra-Cellular Ther's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for Intra-Cellular Stock analysis

When running Intra-Cellular Ther price analysis, check to measure Intra-Cellular Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intra-Cellular Ther is operating at the current time. Most of Intra-Cellular Ther's value examination focuses on studying past and present price action to predict the probability of Intra-Cellular Ther's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Intra-Cellular Ther's price. Additionally, you may evaluate how the addition of Intra-Cellular Ther to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Is Intra-Cellular Ther's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intra-Cellular Ther. If investors know Intra-Cellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intra-Cellular Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
5.2 B
Quarterly Revenue Growth YOY
1.2
Return On Assets
-0.25
Return On Equity
-0.43
The market value of Intra-Cellular Ther is measured differently than its book value, which is the value of Intra-Cellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intra-Cellular Ther's value that differs from its market value or its book value, called intrinsic value, which is Intra-Cellular Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intra-Cellular Ther's market value can be influenced by many factors that don't directly affect Intra-Cellular Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intra-Cellular Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine Intra-Cellular Ther value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intra-Cellular Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.